Once-weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8-GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial). - Curry, N; Albayrak, C; Escobar, M; Andre Holme, P; Kearney, S; Klamroth, R; Misgav, M; Négrier, C; Wheeler, A; Santagostino, E; Shima, M; Landorph, A; et al. (Haemophilia, 2019)